How have ISPC shares performed in 2024?

iSpecimen's stock was trading at $0.5006 on January 1st, 2024. Since then, ISPC shares have decreased by 18.0% and is now trading at $0.4107. View the best growth stocks for 2024 here .

Are investors shorting iSpecimen?

iSpecimen saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 459,500 shares, an increase of 2,826.8% from the March 15th total of 15,700 shares. Based on an average daily volume of 145,700 shares, the days-to-cover ratio is presently 3.2 days. Currently, 8.6% of the shares of the stock are sold short. View iSpecimen's Short Interest .

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our ISPC earnings forecast .

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) issued its earnings results on Wednesday, March, 13th. The company reported ($0.34) EPS for the quarter. The firm had revenue of $2.58 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 80.37% and a negative net margin of 111.81%.

When did iSpecimen IPO?

iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ISPC Stock Alerts

$0.42

+0.21 (+97.65%)

(As of 05:32 PM ET)

Compare

Today's Range: $0.21
▼
$0.57
50-Day Range: $0.21
▼
$0.48
52-Week Range: $0.20
▼
$2.05

Volume: 37.25 million shs
Average Volume: 640,780 shs
Market Capitalization: $3.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get iSpecimen alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About iSpecimen Stock (NASDAQ:ISPC)

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

ISPC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ISPC Stock News Headlines

March 16, 2024 | seekingalpha.com

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

March 16, 2024 | investing.com

Earnings call: iSpecimen reports full-year 2023 results, aims for 2024 profitability

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 15, 2024 | sg.finance.yahoo.com

Nvidia GTC AI conference: What to watch

March 15, 2024 | finance.yahoo.com

iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript

March 15, 2024 | finance.yahoo.com

iSpecimen Full Year 2023 Earnings: Misses Expectations

March 14, 2024 | finanznachrichten.de

iSpecimen Inc: iSpecimen Reports Full Year 2023 Results

March 14, 2024 | globenewswire.com

iSpecimen Reports Full Year 2023 Results

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 13, 2024 | benzinga.com

iSpecimen: Q4 Earnings Insights

March 13, 2024 | nz.finance.yahoo.com

Fed rate cuts likely coming after June -strategist

March 12, 2024 | globenewswire.com

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

March 5, 2024 | globenewswire.com

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

January 23, 2024 | finanznachrichten.de

iSpecimen Inc: iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

January 23, 2024 | markets.businessinsider.com

ISpecimen, TriMetis Life Sciences Announce Partnership For Tissue Research

January 23, 2024 | finance.yahoo.com

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

January 18, 2024 | finance.yahoo.com

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

December 21, 2023 | morningstar.com

iSpecimen Inc ISPC

December 7, 2023 | finance.yahoo.com

iSpecimen Strengthens Global Oncology Biospecimen Offering

November 5, 2023 | finance.yahoo.com

iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript

November 2, 2023 | msn.com

iSpecimen GAAP EPS of -$0.23 beats by $0.12, revenue of $2.78M beats by $0.55M

November 2, 2023 | finance.yahoo.com

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

October 26, 2023 | finance.yahoo.com

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

October 23, 2023 | msn.com

iSpecimen expects Q3 revenue above consensus

October 2, 2023 | bizjournals.com

Biotech layoffs 2023: In Q3, 19 Boston-area biotechs made cuts

September 16, 2023 | finance.yahoo.com

Insider Buying: Benjamin Bielak Acquires 18,000 Shares of iSpecimen Inc

September 13, 2023 | finance.yahoo.com

iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research

See More Headlines

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/13/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:ISPC
CUSIP: N/A
CIK: 1558569
Web: ispecimen.com
Phone: 781-301-6700
Fax: N/A
Employees: 53
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,100,000.00
Net Margins: -111.81%
Pretax Margin: -111.79%
Return on Equity: -80.37%
Return on Assets: -61.99%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.36
Quick Ratio: 1.36

Sales & Book Value

Annual Sales: $9.93 million
Price / Sales: 0.20
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.07 per share
Price / Book: 0.20

Miscellaneous

Outstanding Shares: 9,370,000
Free Float: 6,309,000
Market Cap: $2.00 million
Optionable: Not Optionable
Beta: 1.69

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Ms. Tracy Wilson Curley (Age 62)
CEO, CFO, Treasurer & Director
Comp: $437.5k
Mr. Benjamin Bielak (Age 54)
Chief Information Officer & Secretary
Comp: $391.2k
Ms. Carly Lejnieks
Vice President of Marketing
Ms. Annette Arnold
Vice President of Sales & Business Development
Mr. David Wages M.D.
Ph.D., Chief Medical Officer
Mr. Eric Langlois
Chief Revenue Officer
Mr. Evan Cox
Senior Vice President of Strategy & Innovation

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ISPC Stock Analysis - Frequently Asked Questions

How have ISPC shares performed in 2024?: iSpecimen's stock was trading at $0.5006 on January 1st, 2024. Since then, ISPC shares have decreased by 18.0% and is now trading at $0.4107.
View the best growth stocks for 2024 here.
Are investors shorting iSpecimen?: iSpecimen saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 459,500 shares, an increase of 2,826.8% from the March 15th total of 15,700 shares. Based on an average daily volume of 145,700 shares, the days-to-cover ratio is presently 3.2 days. Currently, 8.6% of the shares of the stock are sold short.
View iSpecimen's Short Interest.
When is iSpecimen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ISPC earnings forecast.
How were iSpecimen's earnings last quarter?: iSpecimen Inc. (NASDAQ:ISPC) issued its earnings results on Wednesday, March, 13th. The company reported ($0.34) EPS for the quarter. The firm had revenue of $2.58 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 80.37% and a negative net margin of 111.81%.

When did iSpecimen IPO?: iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.
How do I buy shares of iSpecimen?: Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ISPC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

iSpecimen (ISPC) Stock Price, News & Analysis

About iSpecimen Stock (NASDAQ:ISPC)

ISPC Stock Price History

ISPC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

ISPC Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info